hoffmanla roche lilly license pact hoffmannla roche licensee hormone research foundation patent synthetic version human growth hormone enter license agreement eli lilly involve lilly humatrope hormone treat dwarfism child detail license agreement disclose company official unavailable comment statement company lilly roche enter license agreement alternative litigation south san franciscobased genetech market genetically engineer human growth hormone call protropin lilly receive approval food drug administration market human growth hormone earlier lilly spokesperson company effect license patent hormone hoffmanlaroche refuse comment term license agreement september hoffmanlaroche foundation sue genetech federal court california allege product infringe hoffman patent synthetic hormone 
